Last reviewed · How we verify
ribavirin, USP
At a glance
| Generic name | ribavirin, USP |
|---|---|
| Also known as | Rebetol® |
| Sponsor | Medtronic Corporate Technologies and New Ventures |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Study to Evaluate the Safety and Efficacy of VIRAZOLE® in Hospitalized Adult Participants With Respiratory Distress Due to COVID-19_#2 (PHASE1)
- Treatment of Hemorrhagic Fever With Ribavirin (PHASE2)
- Study to Evaluate the Safety and Efficacy of VIRAZOLE® in Hospitalized Adult Participants With Respiratory Distress Due to COVID-19 (PHASE1)
- Safety and Efficacy Study to Compare Continuous Infusion of Interferon With Standard of Care for Chronic Hepatitis C (PHASE2)
- Pre-Transplant Treatment to Prevent Recurrence of Hepatitis C After Liver Transplantation (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |